Glucose 20 Braun, 200 mg/ml, solution for infusion
(Glucosum)
You should carefully read the contents of the leaflet before using the medicine, as it contains important information for the patient.
|
Glucose 20 Braun is a glucose solution administered through a cannula into a vein (intravenous infusion).
The medicine Glucose 20 Braun is used to provide the patient with carbohydrates when oral nutrition is impossible or insufficient.
The medicine is also used when it is necessary to increase too low blood sugar levels.
Before starting to use Glucose 20 Braun, you should discuss it with your doctor or nurse.
This medicine should not be administered to a patient during or after a stroke, unless the doctor considers it necessary for treatment.
Before and during the use of this medicine, at regular intervals, you should check the blood sugar, fluid, electrolyte (especially potassium), and acid-base balance levels. For this purpose, blood samples should be taken from the patient. If necessary, the blood sugar level should be adjusted by administering insulin.
Before starting to administer this medicine, you should correct fluid and electrolyte disorders, such as:
The doctor will carefully consider administering this medicine in cases where the patient has:
In the event of blood-brain barrier damage, the doctor will take special precautions, as this medicine may increase intracranial and spinal cord pressure.
Additional supplementation of electrolytes (especially potassium, magnesium, phosphates) and vitamins (especially vitamin B) should be ensured.
Special caution should be exercised when using this medicine in children under 2 years of age. Sudden cessation of infusion administered at a high rate may lead to a significant decrease in blood sugar levels, especially in this patient group.
You should tell your doctor about all medicines the patient is currently taking or has recently taken, as well as any medicines the patient plans to take.
In the event of mixing this medicine with other medicines or substances, the doctor will exercise caution and only use medicines and substances that can be administered together with Glucose 20 Braun.
Glucose 20 Braun should not be mixed with red blood cell concentrate, nor should it be administered simultaneously with blood, or directly before or after through the same infusion set.
If the patient is pregnant or breastfeeding, suspects they may be pregnant, or plans to have a child, they should consult their doctor before using this medicine.
Pregnancy
The doctor will decide whether to use this medicine during pregnancy. During the use of this medicine, blood sugar levels should be monitored.
Breastfeeding
The doctor will decide whether to use this medicine during breastfeeding.
Glucose 20 Braun does not affect the ability to drive and use machines.
The dose of Glucose 20 Braun will be determined by the doctor based on the patient's health condition.
In the case of adults and adolescents over 15 years of age, the maximum dose of the medicine is 30 ml per kg of body weight per day. The medicine should not be administered at a rate greater than 1.25 ml per kg of body weight per hour.
In the case of children under 14 years of age, the maximum daily dose of the medicine will be determined based on age and body weight:
Preterm infants:
90 ml per kg of body weight
Newborns:
75 ml per kg of body weight
Children 1-2 years old:
75 ml per kg of body weight
Children 3-5 years old:
60 ml per kg of body weight
Children 6-10 years old:
50 ml per kg of body weight
Children 11-14 years old:
40 ml per kg of body weight
When determining the dose, the daily fluid intake should be taken into account, in accordance with the following recommendations for children:
first day of life:
In the case of metabolic disorders (e.g. after surgery or injury, in cases of insufficient tissue oxygenation, or in cases of organ diseases), the glucose dose should be adjusted to ensure normal blood glucose levels.
Glucose 20 Braun is administered through a cannula directly into a vein (intravenous infusion).
During parenteral nutrition, the patient is also administered other nutrients, such as amino acids as a protein builder, fat emulsions, saturated fatty acids, electrolytes, vitamins, and trace elements.
Since the daily doses are determined by the doctor, the use of a higher dose is unlikely.
Overdose of the medicine may lead to increased blood sugar levels, glucose excretion in the urine, increased fluid levels, fluid deficiency, disorder or loss of consciousness due to high blood sugar levels or excessive fluid concentration, fluid overload with accompanying skin tension, venous thrombosis (feeling of heaviness and swelling of the legs), tissue edema (possible in the event of fluid accumulation in the lungs or brain edema), and increased electrolyte levels in the blood. In the event of a very high overdose, it may also lead to fat accumulation in the liver.
In such a case, the infusion should be slowed down or stopped if necessary.
The doctor will decide on further treatment steps, e.g. administration of insulin, fluids, or electrolytes.
You should consult a doctor or pharmacist if you need advice or additional information about using this medicine.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
If this medicine is used as recommended, you should not expect side effects.
After the medicinal product has been placed on the market, it is important to report suspected side effects. This allows for continuous monitoring of the benefit-risk balance of the medicinal product. Healthcare professionals should report any suspected side effects via the Department of Adverse Reaction Monitoring of Medicinal Products, Medical Devices, and Biocidal Products, Al. Jerozolimskie 181C, 02-222 Warsaw, Tel.: +48 22 49 21 301, Fax: +48 22 49 21 309, website: https://smz.ezdrowie.gov.pl.
By reporting side effects, you can help provide more information on the safety of this medicine.
Store in a place inaccessible and invisible to children.
Do not use this medicine after the expiry date stated on the label and carton. The expiry date refers to the last day of the given month.
Use the product only if the solution is clear or slightly yellowish and the packaging and closure are undamaged.
There are no special precautions for storage.
Glucose 20 Braun is a solution for infusion (for administration through an infusion fluid transfusion apparatus.
It is a clear, colorless or slightly yellowish glucose monohydrate solution in water.
Glucose 20 Braun is supplied in:
Information intended for healthcare professionals only:
Method of administration
For intravenous infusion only.
Children
For the treatment of hypoglycemia in children, a 10% glucose solution is recommended.
Due to the high osmolality, special caution should be exercised when using Glucose 20 Braun in newborns.
Special warnings and precautions for use
Sudden cessation of glucose infusion administered at a high rate may lead to severe hypoglycemia due to high insulin levels in the serum. This applies especially to children under 2 years of age, patients with diabetes, and other diseases associated with impaired glucose homeostasis.
Obviously, the glucose infusion should be tapered off over 30-60 minutes. As a precaution, it is recommended to monitor each patient for 30 minutes for hypoglycemia on the first day after discontinuation of parenteral nutrition.
Shelf life after first opening of the package
The infusion should be started immediately after connecting the container with the medicine to the infusion fluid transfusion apparatus.
Shelf life of the medicinal product after mixing with other substances
From a microbiological point of view, mixtures with additives or other infusion solutions should be used immediately. If not used immediately, the user is responsible for the storage conditions and storage time before administration of the medicine. The storage time should not exceed 24 hours at a temperature of 2 to 8°C, unless the preparation was carried out under controlled and validated aseptic conditions.
Incompatibilities
Due to the acidic pH, the medicine may not be compatible with other medicinal products.
Due to the risk of pseudoagglutination, a suspension should not be created with erythrocyte concentrates in Glucose 20 Braun.
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.